Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.
published in: Oncotarget
date of publication: 2016-04-01
language: English
main subject: antibody, non-small-cell lung carcinoma
Cites articles 55
- 2014-11-15
Date
Title
Article - wd:Q37190106